Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management.
EBioMedicine
; 80: 104038, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35500537
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Diabetes Mellitus, Type 2
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
EBioMedicine
Year:
2022
Document type:
Article
Country of publication: